Psoriasis

N Engl J Med. 2005 Aug 25;353(8):848-50; author reply 848-50.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Humans
  • Psoriasis / drug therapy*
  • Psoriasis / etiology*
  • Risk Factors

Substances

  • Adrenergic beta-Antagonists